These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 28421980

  • 1. Guidelines for the recognition and management of mixed depression.
    Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, Thase ME, Vieta E, Young A, Zimmerman M, McIntyre RS.
    CNS Spectr; 2017 Apr; 22(2):203-219. PubMed ID: 28421980
    [Abstract] [Full Text] [Related]

  • 2. What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?
    Faedda GL, Marangoni C.
    CNS Spectr; 2017 Apr; 22(2):120-125. PubMed ID: 27831463
    [Abstract] [Full Text] [Related]

  • 3. Dysphoric mania, mixed states, and mania with mixed features specifier: are we mixing things up?
    McElroy SL, Keck PE.
    CNS Spectr; 2017 Apr; 22(2):170-176. PubMed ID: 27866502
    [Abstract] [Full Text] [Related]

  • 4. Measures of the DSM-5 mixed-features specifier of major depressive disorder.
    Zimmerman M.
    CNS Spectr; 2017 Apr; 22(2):196-202. PubMed ID: 28077190
    [Abstract] [Full Text] [Related]

  • 5. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M.
    CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
    [Abstract] [Full Text] [Related]

  • 6. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 7. Mixed features in major depressive disorder: diagnoses and treatments.
    Suppes T, Ostacher M.
    CNS Spectr; 2017 Apr; 22(2):155-160. PubMed ID: 28462772
    [Abstract] [Full Text] [Related]

  • 8. Antidepressant response and subthreshold bipolarity in "unipolar" major depressive disorder: implications for practice and drug research.
    Rihmer Z, Dome P, Gonda X.
    J Clin Psychopharmacol; 2013 Aug; 33(4):449-52. PubMed ID: 23775059
    [No Abstract] [Full Text] [Related]

  • 9. Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications.
    Malhi GS, Byrow Y, Outhred T, Fritz K.
    CNS Spectr; 2017 Apr; 22(2):126-133. PubMed ID: 27869049
    [Abstract] [Full Text] [Related]

  • 10. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
    McIntyre RS, Soczynska JK, Cha DS, Woldeyohannes HO, Dale RS, Alsuwaidan MT, Gallaugher LA, Mansur RB, Muzina DJ, Carvalho A, Kennedy SH.
    J Affect Disord; 2015 Feb 01; 172():259-64. PubMed ID: 25451425
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatment of mixed states.
    Cuomo A, Nikolova VL, Yalin N, Arnone D, Fagiolini A, Young AH.
    CNS Spectr; 2017 Apr 01; 22(2):186-195. PubMed ID: 28416033
    [Abstract] [Full Text] [Related]

  • 12. Mixed features and mixed states in psychiatry: from calculus to geometry.
    McIntyre RS.
    CNS Spectr; 2017 Apr 01; 22(2):116-117. PubMed ID: 28264727
    [No Abstract] [Full Text] [Related]

  • 13. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L, Vázquez GH, Pinna M, Vaccotto PA, Baldessarini RJ.
    Acta Psychiatr Scand; 2018 Sep 01; 138(3):243-252. PubMed ID: 29862493
    [Abstract] [Full Text] [Related]

  • 14. Towards a reconceptualization of mixed states, based on an emotional-reactivity dimensional model.
    Henry C, M'Baïlara K, Desage A, Gard S, Misdrahi D, Vieta E.
    J Affect Disord; 2007 Aug 01; 101(1-3):35-41. PubMed ID: 17240456
    [Abstract] [Full Text] [Related]

  • 15. [Recommendations for the treatment of mixed episodes in current guidelines].
    Azorin JM, Belzeaux R, Cermolacce M, Kaladjian A, Corréard N, Dassa D, Dubois M, Maurel M, Micoulaud Franchi JA, Pringuey D, Fakra E.
    Encephale; 2013 Dec 01; 39 Suppl 3():S185-7. PubMed ID: 24359859
    [Abstract] [Full Text] [Related]

  • 16. A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders.
    McIntyre RS, Lee Y, Mansur RB.
    CNS Spectr; 2016 Dec 01; 21(S1):25-33. PubMed ID: 28044944
    [Abstract] [Full Text] [Related]

  • 17. Agitated depression in bipolar II disorder.
    Benazzi F.
    World J Biol Psychiatry; 2005 Dec 01; 6(3):198-205. PubMed ID: 16166029
    [Abstract] [Full Text] [Related]

  • 18. Mixed features: evolution of the concept, past and current definitions, and future prospects.
    Swann AC.
    CNS Spectr; 2017 Apr 01; 22(2):161-169. PubMed ID: 28264741
    [Abstract] [Full Text] [Related]

  • 19. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS, Benazzi F.
    J Affect Disord; 2006 Aug 01; 94(1-3):105-10. PubMed ID: 16766043
    [Abstract] [Full Text] [Related]

  • 20. Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study.
    Petri E, Bacci O, Barbuti M, Pacchiarotti I, Azorin JM, Angst J, Bowden CL, Mosolov S, Vieta E, Young AH, Perugi G, BRIDGE-II-Mix Study Group.
    Bipolar Disord; 2017 Sep 01; 19(6):458-464. PubMed ID: 28691250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.